Skip to content
akaturk Academic measurement

OpenAlex topic

Neurotransmitter Receptor Influence on Behavior

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,838 works 80 author topics

Works

1,838 works

  1. YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.6%

    No abstract yet.

  2. OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Some, although not all, studies report small hippocampal volume in patients with major depressive disorder (MDD) relative to healthy controls. Here, we explore the contribution of key demographic and clinical variables to this difference. METHODS: We used meta-analytic techniques to provide an updated anal…

  3. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.8%

    No abstract yet.

  4. YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.0%

    No abstract yet.

  5. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.3%

    No abstract yet.

  6. YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.5%

    BACKGROUND: Abnormalities in cortico-striatal-pallidal-thalamic (CSPT) circuits have been implicated in major depressive disorder (MDD). However, the robustness of these findings across studies is unclear, as is the extent to which they are influenced by demographic, clinical and pharmacological factors. METHOD: With…

  7. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.1%

    No abstract yet.

  8. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.2%

    No abstract yet.

  9. OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  10. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.4%

    No abstract yet.

  11. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low and the percentage with relapse is high. The efficacy and safety of esketamine nasal spray as compared with…

  12. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low and the percentage with relapse is high. The efficacy and safety of esketamine nasal spray as compared with…

Academicians

80 academicians